Lansen Pharmaceutical Holdings Limited is a Hong Kong-based specialty pharmaceutical company engaged in the development, production and sale of specialty prescription western pharmaceuticals for the treatment of autoimmune rheumatic diseases in the People鈥檚 Republic of China. The Company sells its products to over 500 direct customers, which comprise distributor customers who then sell them to hospitals, local distributors and retail pharmacies, and other customers throughout China. It has two business units: rheumatic specialty prescription western pharmaceuticals; and other pharmaceuticals. Its core business comprises five rheumatic specialty prescription western pharmaceuticals, of which only Pafulin is manufactured and sold by the Company and four are not manufactured but are sold by the Company under agency distribution arrangements. As at December 31, 2009, its sales and distribution network covered over 1,000 hospitals in 25 provinces and four municipal cities.

Lansen Pharmaceutical Holdings Ltd a specialty pharmaceutical group principally engaged in the development,production and sale of specialty prescription western pharmaceuticals for the treatment of rheumatic diseases in the PRC.